MYO5B and cholestasis: MYO5B-PFIC is a phenotype with predominant cholestatic liver disease, which is clinically indistinguishable from low-GGT PFIC.7 This clinical phenotype is similar to our reported case with refractory cholestasis with minimal bowel involvement.